Solventum Corp (fka 3M Health Care) Files 8-K
Ticker: SOLV · Form: 8-K · Filed: Aug 22, 2025 · CIK: 1964738
| Field | Detail |
|---|---|
| Company | Solventum Corp (SOLV) |
| Form Type | 8-K |
| Filed Date | Aug 22, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $1,750,000,000, $1,250,000,000, $500,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, name-change, company-information
Related Tickers: MMM
TL;DR
Solventum Corp, formerly 3M Health Care, filed its 8-K on 8/22/25.
AI Summary
Solventum Corporation, formerly 3M Health Care Co., filed an 8-K on August 22, 2025, reporting other events and financial statements. The company, incorporated in Delaware, is headquartered at 3M Center, Building 275-6W, St. Paul, MN 55144, with a principal executive office address at 3M Center, Building 275-6W, Maplewood, Minnesota 55144. The filing indicates a name change from 3M Health Care Co. to Solventum Corporation on February 3, 2023.
Why It Matters
This filing formally documents Solventum Corporation's existence and its previous identity as 3M Health Care Co., providing key corporate and address information for investors and stakeholders.
Risk Assessment
Risk Level: low — This is a routine corporate filing that primarily confirms identity and address information, with no immediate financial or operational risks indicated.
Key Numbers
- 001-41968 — SEC File Number (Identifies the company's filing with the SEC.)
- 92-2008841 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Solventum Corp (company) — Registrant
- 3M Health Care Co. (company) — Former Name
- 3M Company (company) — Associated Company (Business/Mail Address)
- August 22, 2025 (date) — Report Date
- February 3, 2023 (date) — Date of Name Change
- Delaware (jurisdiction) — State of Incorporation
- St. Paul, MN 55144 (address) — Business Address
- Maplewood, Minnesota 55144 (address) — Principal Executive Offices Address
FAQ
What is the primary purpose of this 8-K filing for Solventum Corporation?
The primary purpose is to report 'Other Events' and 'Financial Statements and Exhibits', and to formally document the company's identity and address, including its former name as 3M Health Care Co.
When did the company officially change its name from 3M Health Care Co. to Solventum Corporation?
The date of the name change was February 3, 2023.
What are the principal executive offices of Solventum Corporation?
The principal executive offices are located at 3M Center, Building 275-6W, East, Maplewood, Minnesota 55144.
What is Solventum Corporation's state of incorporation?
Solventum Corporation is incorporated in Delaware.
What is the SEC file number for Solventum Corporation?
The SEC file number for Solventum Corporation is 001-41968.
Filing Stats: 643 words · 3 min read · ~2 pages · Grade level 10.2 · Accepted 2025-08-22 08:25:44
Key Financial Figures
- $1,750,000,000 — es of the series listed below for up to $1,750,000,000 aggregate purchase price. The Company i
- $1,250,000,000 — or an aggregate purchase price of up to $1,250,000,000 and (ii) its 6.000% Senior Notes due 20
- $500,000,000 — or an aggregate purchase price of up to $500,000,000. The 2027 Notes will also be subject to
Filing Documents
- solv-20250822.htm (8-K) — 26KB
- tender-ex991pressrelease.htm (EX-99.1) — 50KB
- image_0a.jpg (GRAPHIC) — 85KB
- 0001964738-25-000073.txt ( ) — 317KB
- solv-20250822.xsd (EX-101.SCH) — 2KB
- solv-20250822_lab.xml (EX-101.LAB) — 22KB
- solv-20250822_pre.xml (EX-101.PRE) — 13KB
- solv-20250822_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On August 22, 2025, Solventum Corporation (the "Company") issued a press release announcing the commencement of cash tender offers (the "Tender Offers") to purchase the Company's outstanding notes of the series listed below for up to $1,750,000,000 aggregate purchase price. The Company is offering to purchase (i) its 5.450% Senior Notes due 2027 (the "2027 Notes"), 5.400% Senior Notes due 2029, 5.600% Senior Notes due 2034 and 5.450% Senior Notes due 2031 for an aggregate purchase price of up to $1,250,000,000 and (ii) its 6.000% Senior Notes due 2064 and 5.900% Senior Notes due 2054 for an aggregate purchase price of up to $500,000,000. The 2027 Notes will also be subject to an aggregate purchase price sublimit of $500,000,000. The Tender Offers are subject to the terms and conditions (including a financing condition) set forth in an offer to purchase, dated August 22, 2025 (the "Offer to Purchase"). A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 8.01 by reference. The information contained in this Current Report on Form 8-K does not constitute an offer to sell, a solicitation to buy, or an offer to purchase any securities. The Tender Offers are being made only pursuant to the Offer to Purchase. The Tender Offers are being made only in such jurisdictions as is permitted under applicable law.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits (d) Exhibits Exhibit Number Description 99.1 Press release announcing the launch of the Tender Offers, dated August 22, 2025 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. SOLVENTUM CORPORATION By: /s/ Wayde McMillan Wayde McMillan Executive Vice President and Chief Financial Officer Dated: August 22, 2025